Endometriosis
Open accessThe DOI matches its Crossref record; 208 of the 214 references it cites were found in a registry or an index.
Abstract
Pelvic endometriosis is a complex syndrome characterized by an estrogen-dependent chronic inflammatory process that affects primarily pelvic tissues, including the ovaries. It is caused when shed endometrial tissue travels retrograde into the lower abdominal cavity. Endometriosis is the most common cause of chronic pelvic pain in women and is associated with infertility. The underlying pathologic mechanisms in the intracavitary endometrium and extrauterine endometriotic tissue involve defectively programmed endometrial mesenchymal progenitor/stem cells. Although endometriotic stromal cells, which compose the bulk of endometriotic lesions, do not carry somatic mutations, they demonstrate specific epigenetic abnormalities that alter expression of key transcription factors. For example, GATA-binding factor-6 overexpression transforms an endometrial stromal cell to an endometriotic phenotype, and steroidogenic factor-1 overexpression causes excessive production of estrogen, which drives inflammation via pathologically high levels of estrogen receptor-β. Progesterone receptor deficiency causes progesterone resistance. Populations of endometrial and endometriotic epithelial cells also harbor multiple cancer driver mutations, such as KRAS, which may be associated with the establishment of pelvic endometriosis or ovarian cancer. It is not known how interactions between epigenomically defective stromal cells and the mutated genes in epithelial cells contribute to the pathogenesis of endometriosis. Endometriosis-associated pelvic pain is managed by suppression of ovulatory menses and estrogen production, cyclooxygenase inhibitors, and surgical removal of pelvic lesions, and in vitro fertilization is frequently used to overcome infertility. Although novel targeted treatments are becoming available, as endometriosis pathophysiology is better understood, preventive approaches such as long-term ovulation suppression may play a critical role in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since P4 signaling is required to counteract E2-induced proliferation and to promote decidualization [55], the loss of P4-responsiveness leads to both an increased growth of endometriotic lesions and to a non-receptive endometrium [33, 56].”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During the follicular phase, estrogen acts on eutopic endometrium through the estrogen receptor (ER) to increase transcription and protein levels of the progesterone receptor (PR), especially the PR-B isoform.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in endometriotic implants, ERα is reduced but ERβ activity is upregulated, leading to complete loss of PR-B, which is then unable to induce 17β-HSD2.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clear data show that endometriotic tissue expresses the entire set of steroidogenic genes, including aromatase, allowing to local de-novo estradiol (E2) production. [33]”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“PR resistance in endometriotic cells results in CRABP2 deficiency, thereby favoring survival, development and persistence of endometriotic implants [15,16].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [15]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Self-citationARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Eskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
(1927) · PubMed Central · Cited by 1,008
Immunobiology of endometriosis
Lebovic, D. I., Mueller, M. D., & Taylor, R. N. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01630-7 · Cited by 857
Cited by
Items 801–900 of 944
Lee, S. H., Lim, C. L., Shen, W., Tan, S. M. X., Woo, A. R. E., Yap, Y. H. Y., Sian, C. A. S., Goh, W. W. B., Yu, W.-P., Li, L., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21285882
Robin, C., Uk, A., Decanter, C., Behal, H., Collinet, P., Rubod, C., Barbotin, A.-L., & Robin, G. (2021) · Figshare · doi:10.6084/m9.figshare.16822744
Wang, X., Wang, J., Zhao, X., Wu, H., Li, J., Cheng, Y., Guo, Q., Cao, X., Liang, T., Sun, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26599214
Wang, Z., Zhan, C., Liao, L., Luo, Y., Lin, S., & Yan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26743145
Wang, Z., Zhan, C., Liao, L., Luo, Y., Lin, S., & Yan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26743139
Parke, S., Gude, K., Roth, K., & Messina, F. (2024) · Figshare · doi:10.6084/m9.figshare.26061474
Wang, Z., Zhan, C., Liao, L., Luo, Y., Lin, S., & Yan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26182184
Bumgarner, A. (2025) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/krw5-ep42
Wang, Z., Zhan, C., Liao, L., Luo, Y., Lin, S., & Yan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26182312
Wang, Z., Zhan, C., Liao, L., Luo, Y., Lin, S., & Yan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26743151
Ishikawa, H., Yoshino, O., Taniguchi, F., Harada, T., Momoeda, M., Osuga, Y., Hikake, T., Hattori, Y., Hanawa, M., Inaba, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25092522
Wang, Z., Zhan, C., Liao, L., Luo, Y., Lin, S., & Yan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26743154
Wang, Z., Zhan, C., Liao, L., Luo, Y., Lin, S., & Yan, S. (2024) · Figshare · doi:10.6084/m9.figshare.26743142
Impact of endometriosis on quality of life in women : a descriptive literature review
Oladeji, O., & Ikram, A. (2024) · Theseus (Ammattikorkeakoulujen)
Att leva med en osynlig sjukdom: En kvalitativ studie om unga kvinnors upplevelser av endometrios
Granlund, V. (2021) · Theseus (Ammattikorkeakoulujen)
The effects of physical activity on the mental health of women suffering from endometriosis
Rúnarsdóttir, T. R. (2023) · Skemman
Vpliv bolečine na kakovost življenja žensk z endometriozo
Oprešnik, K. (2024) · Repository of the University of Ljubljana (University of Ljubljana)
Cesarean Scar Endometriosis Incidence and Risk Factors After Primary Cesarean Delivery
Luna Ramirez, N., & Luna Ramirez, N. (2024) · UA Campus Repository (The University of Arizona) · Cited by 1
Att leva med sjukdomen endometrios : En kvalitativ litteraturöversikt
Adey, E., & Holmberg, M. (2023) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Hur kvinnor med endometrios upplever mötet med vården : En kvalitativ litteraturstudie
Gustafsson, J., & Freij, T. (2024) · DiVA (Linkoping University)
Endometrios, det osynliga och okända lidandet : En allmän litteraturstudie
Ghadirian, S., & Halefom, M. (2024) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Vloga medicinske sestre pri obravnavi ženske z endometriozo
Varga, E. (2023) · Repository of the University of Ljubljana (University of Ljubljana)
Peptide-based drug carriers and preclinical nanomedicine applications for endometriosis treatment
Kiisholts, K. (2023) · DSpace repository (University of Tartu) · Cited by 17
Ebeling, G. S. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-49312
Farmácia D'Arrábida, Vila Nova de Gaia
Santos, F. M. D. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/bcnk-mm98
Women’s experiences of pain in endometriosis : A general literature review
Svensson, J., & Hasselqvist, E. (2023) · Hogskolan Ihalmstad (Halmstad University)
Endometriosis: the role of diet and genetics
Τσάβου, Ε.-Ά. Ε., & Χατζηγιάννη, Ι. Η. (2024) · University of Thessaly Institutional Repository (University of Thessaly)
Endometriosis and Brown Adipose Tissue Activity
Crespi, B., Prior, J. C., Yong, P. J., Purcell, S. A., Chen, M. X., Shirazian, N., & Shirin, S. (2024) · cIRcle (University of British Columbia)
Association Between Remnant Cholesterol and Endometriosis Findings from NHANES 1999–2006
Su, L., Wang, X., Zhang, J., Xu, R., Ren, Y., & Wang, S. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s568397
“2,4,5 Despite extensive research, the precise causes of endometriosis remain elusive.”
Inovar, E. (2025) · Editora Inovar eBooks · doi:10.36926/editorainovar-978-65-5388-366-6
Transcriptome profiling to identify blood biomarkers for peritoneal endometriosisPreprint
Pušić, M. N., Vižintin, A., Režen, T., Frangež, H. B., Wenzl, R. J., & Rižner, T. L. (2025) · medRxiv · doi:10.64898/2025.12.23.25342915
Klinikte Endometriozis ve Polikistik Over Sendromu Yönetimi
Adalı, A., Yıldırım, F., & Duman, N. B. (2025) · Hitit sağlık dergisi. · doi:10.69563/hititsaglikderg.1726835
Tompeen, I. (2026) · HEALTH SCIENCES AND DISEASE · doi:10.5281/zenodo.18078094
Hamutoğlu, R., Kaloğlu, C., Bulut, H. E., & Yıldız, Ç. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1625031
“Endometriosis is an estrogen-dependent chronic inflammatory condition closely linked to severe pelvic pain, progressive dysmenorrhea, dyspareunia, and subfertility (Brown and Farquhar, 2014; Bedaiwy et al., 2017; Alimi et al., 2018; Coxon et al., 2018; Grogan et al., 2018; Bulun et al., 2019).”
Gene Expression Signature in Women with Endometriosis: An In Silico Approach
Melo, V. B. (2025) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
A new approach in the Italian landscape of chronic pelvic pain and endometriosis
Candiani, M., Lazzeri, L., Maiorana, A., Muzii, L., Vignali, M., Vizza, E., & Zupi, E. (2026) · Italian Journal of Gynaecology and Obstetrics · doi:10.36129/jog.2026.258
Farmácia Coimbrões, Vila Nova de Gaia
Soares, B. S. J. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/c1vg-gj47
Radziwon, M., Borowski, K., Pastuszek, O., Bolesta-Okuniewska, E., Michalak, P., Marchwińska-Pancer, A., Kopeć, K., Ceryn, J., & Wicher, A. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.87.67559
Wijaya, A. P., Hendarto, H., & Kusumah, I. P. (2026) · Indonesian Journal of Multidisciplinary Science · doi:10.55324/ijoms.v5i4.1234
Tang, N., Luo, C., Hu, L., & Xu, F. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s553824
García, C. R. (2023) · UCrea (University of Cantabria)
Gomes, M. S. L. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Park, Y., Park, H., Lee, I., Lee, J. H., Cho, S., & Choi, Y. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1746451
miR-130b-5p Regulates Expression of ERβ via IGFBP2/SREBP1 Axis in Human Endometriotic Stromal Cells
Wu, P., Zhu, J., & Xue, Q. (2026) · Reproductive Sciences · doi:10.1007/s43032-025-02036-w
Relationship between endometriosis diagnosis, staging, and typology and inflammatory cytokines
Shaaban, M., Ryan, J. T., Adediran, E., Farland, L. V., Pollack, A. Z., Peterson, C. M., Rexrode, K. M., Hemmert, R. B., Paulsen, M., Brown, B. H., et al. (2026) · F&S Reports · doi:10.1016/j.xfre.2026.02.007 · Cited by 1
Obstetric outcomes in women with endometriosis: A retrospective cohort study
Chaudhari, M., Suthar, M. B., & Patel, J. P. (2026) · International Journal of Clinical Obstetrics and Gynaecology · doi:10.33545/gynae.2026.v10.i1m.1993
Proposed Role of RGS1 in Modulating IL-1β-IL-1R1-IRAK4-TAK1 Signaling in Endometriotic Stromal Cells
Tsuzuki, Y., Tarumi, Y., Minami, T., Ito, F., Shimura, K., Katayama, A., Izumi, Y., Kitawaki, J., & Mori, T. (2026) · Reproductive Sciences · doi:10.1007/s43032-025-02014-2
Fuertes, T. L. (2024) · e_Buah · Cited by 1
Endometriomas are heterogeneous for functional FSH receptor expression and steroidogenic function
Benlioğlu, C., Esmaeilian, Y., Yusufoğlu, S., Kalajahi, H. G., Altay, B., Ateş, S., Aydın, S., Kalkan, Ü., Bulutay, P., Açılan, C., et al. (2026) · Molecular Human Reproduction · doi:10.1093/molehr/gaag014
Tratamento farmacológico contemporâneo para endometriose: uma revisão baseada em evidências clínicas
Weber, H., Bosch, C. H. W., Pillati, H. G. D. S., Belotto, N. A., Belotto, C. A., Brambila, M. A., Plautz, M. E., Giehl, E. S., da Veiga, M. E., Altreider, E., et al. (2026) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.19n.3-008
Gu, Z. (2026) · Health Science Reports · doi:10.1002/hsr2.71609
“For endometriosis pathogenesis, which involves ectopic endometrial growth mediated by retrograde menstruation and estrogen‐dependent mechanisms [24, 25], LEO demonstrates multi‐target therapeutic effects.”
Tsai, M.-H., Weng, S., Su, L.-J., & Lai, T. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062572
“…therapies that counteract endometrial proliferation are prioritized: progestins and oestro-progestins are widely used to alleviate EM-associated pain by suppressing endometrial growth and inducing secretory transformation [69], although a subset of patients exhibits progesterone resistance [4].”
Sun, F., Wang, S., Zhao, J., Leng, J., Zhu, X., Liu, C., Chen, J., Guo, J., Jiang, B., Zhou, H., et al. (2026) · Cell Proliferation · doi:10.1111/cpr.70197
Iwuagwu, C., Chen, L. X., Slattery, E., Srivastava, P., Karra, H., Tung, S., Burton, A., Bomtempo, C., & Aranda, J. (2026) · Women s Health Reports · doi:10.1177/26884844261420627
Davuluri, V. N. G., Dias, M., Llinas, R. J., Neha, K., Popli, P., Hawkins, S. M., Tayade, C., Courtois, E. T., Yalamanchili, H. K., & Kommagani, R. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03015-z
“However, retrograde menstruation occurs in most women, and only a subset goes on to develop endometriosis, suggesting that additional factors such as immune dysfunction, environmental toxins, hormonal imbalances, and cellular reprogramming contribute to lesion establishment and progression [5 – 7].”
Evolution of the genetic architecture of uterine disordersPreprint
Liorzou, E., Julienne, H., Daunesse, M., Laval, G., Aschard, H., & Berthelot, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.713926
MYC: unveiling novel therapeutic avenues for endometriosis
Ge, X., Yue, C., Zhang, M., Wang, M., Liu, J., Jiang, A., & Yu, Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11716-y
Coelho, L. H. D. S., Junqueira, M. C. G., & Alves, L. J. (2026) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v7i4.7569
Abdulwahed, A., Alanazi, F., Farzan, R. A., Alqahtani, M. M., Al-Sharafa, M. M., Alselmi, T. F., Alasiri, G. A., Shahbaz, R. H., Alanazi, N. T., Alanazi, M. A. S., et al. (2026) · Medicine · doi:10.1097/md.0000000000048143 · Cited by 1
“[6,7] The condition typically presents with chronic pelvic pain, dysmenorrhea, dyspareunia, and potential infertility, though symptom severity correlates poorly with disease extent.”
de Wilde, M. S. (2026) · Carl von Ossiezky University of Oldenburg
From Gene Networks to Repurposed Drugs: A Systems Biomedicine Approach to Endometriosis Management
Taş, F. D., & Aydın, B. (2026) · Genel Tıp Dergisi · doi:10.54005/geneltip.1812858
Perelmuter, S. (2026) · Preprints.org · doi:10.20944/preprints202604.0081.v1
Pocate-Cheriet, K. (2020) · theses.fr (ABES) · doi:10.70675/8a1fbb23z175dz4bbcz8427z6f4af93f23d1
Gao, G., Duan, L., Zhu, F., Dai, W., Geng, L., Liu, D., Lin, J., Zhao, H., Wang, Y., & Li, C. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02655-z
“While the precise mechanisms underlying the attenuated progesterone response in EM patients remain incompletely understood, multiple studies suggest that PGR deficiency is a major cause of progesterone resistance [38, 39].”
Analyse des micro-ARN dans le cadre de l'endométriose : apport clinico-biologique
Dabi, Y. (2023) · theses.fr (ABES) · doi:10.70675/ee221eccza824z4ddezbeb8z04286230c430
A rare case of appendicular endometriosis mimicking appendicitis: a case report
Abadi, A., Ghanem, U. I., Melhem, L., Mallah, O., & Hodali, A. (2026) · Research Connections · doi:10.1093/rescon/vmag041
Malignancy History in Patients with Endometriosis: A Retrospective Observational Study
Güzelbağ, B., Pişkin, N., Bestel, A., ÇELİK, E., & Çelik, H. G. (2026) · Türk Üreme Tıbbı ve Cerrahisi Dergisi · doi:10.24074/tjrms.2026-116989
Berlanda, N., Bandini, V., Croci, G. A., Dridi, D., Nobili, M. V., Cipriani, S., & Vercellini, P. (2026) · Human Reproduction · doi:10.1093/humrep/deag059
Frota, G. M., Santos, W. G. B., Tenório‐Meireles, J., Silva, E. R., REIS, A. T. F., Santos, R. A. P., de Sousa, L. R., Carvalho, R. A. F., Sousa, J. C. D. S., de Sousa, E. M., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19040641
刘, 少. (2026) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2026.52170
卢, 思. (2025) · 健康文摘 · doi:10.61654/zzjkwz1103
Zhang, H., & Luo, Y. (2026) · Human Mutation · doi:10.1155/humu/5565366
“The diverse composition and functional states of cellular populations present in the ectopic endometrial microenvironment have recently been recognized as major drivers of patient prognosis [7–9].”
Wang, H., Gou, Y., Zhang, H., Wang, H., Wang, B., Liu, J., Cao, Y., Bai, R., Zhao, Y., Han, X., et al. (2026) · Advanced Science · doi:10.1002/advs.75442
Endometriosis in adolescents: A literature review
Cauchin, C., Jamard, E., Bendifallah, S., & Fauvet, R. (2026) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2026.103204
Kocas, H. D., Polanco-Roman, L. A., Lobel, M., Seckin, T. A., & Rubin, L. R. (2026) · Journal of Endometriosis and Uterine Disorders · doi:10.1016/j.jeud.2026.100164
Endometriose und ihre Auswirkungen auf das Sexualleben
Falconnier, A., & Schulte, V. (2026) · Springer eBooks · doi:10.1007/978-3-662-72774-4_1
Terazosin as a Non-Hormonal Treatment for Endometriosis
Beyazıt, A., Tutuk, O., & Kuzuluk, D. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094093
Burka, S., Rodriguez, C. P., Elder-Odame, P., & Michos, E. D. (2026) · Springer eBooks · doi:10.1007/978-3-032-18203-6_3
Endometriosis and Polycystic Ovarian Syndrome
Antonakis, L., & Adonakis, G. (2026) · Springer eBooks · doi:10.1007/978-3-032-05381-7_18
Resveratrol as a protective and ameliorative agent in endometriosis
Al-Salamy, A. A., & Alghetaa, H. (2026) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265261438168
Jiang, H., Tang, Y., Huang, X., Wang, Z., & 林发全 (2026) · Medicine · doi:10.1097/md.0000000000048562
“[1] Endometriosis is a common disorder resulting infertility in women.”
Grigoryants, A. A., Makarova, K. A., Musayeva, M. S., Baysaeva, M. A., & Bagova, A. J. (2026) · V F Snegirev Archives of Obstetrics and Gynecology · doi:10.17816/aog701761
“[32, 33], хроническое воспаление и локальная гормональная дисрегуляция поддерживают патологическую стромальную микросреду, нарушающую регуляцию фолликулогенеза.”
Application of 18F ‐ FAPI PET / CT in Deep Infiltrating Endometriosis
Chen, T., Cai, R., Li, M., Yu, P., Wang, X., Huang, Y. Q., & Li, H. (2026) · Clinical Case Reports · doi:10.1002/ccr3.72676
Tiwari, S., & Paul, N. (2026) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2026.19.2.1080
Zheng, J. H., Yao, Y., Chen, X., Fu, L., Chi, Y., Zhong, Z.-H., & Ding, Y. (2026) · Mediators of Inflammation · doi:10.1155/mi/6617402
“Furthermore, ALPI helps regulate intestinal in fl ammation and maintain gut barrier integrity, which is crucial since dysregulated in fl ammation and increased intestinal permeability are associated with EM [44, 45].”
Louwagie, E., & Fodera, D. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-10745-9_6
A Review of the Potential Therapeutic Benefits of Quercetin for Uterine-Related Conditions
Leone, M. A., Kurman, G., Bright, M., Gregersen, P. K., & Metz, C. N. (2026) · Biomedicines · doi:10.3390/biomedicines14061205
Goyal, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.27.728028
Muraoka, A., Yokoi, A., & Kajiyama, H. (2026) · Communications Medicine · doi:10.1038/s43856-026-01704-5
“Locally, the expression of aromatase(akeyenzymeinthebiosynthesisofestrogens)andsteroidogenic acuteregulatoryproteinsareincreasedtoproduceestrogen,whichcauses localizedelevationsofestrogeninendometrioticlesions 3 .”
MuDanLiFu, H., Huang, S., Li, Y., Liang, Y. I. X. I. U., Zhao, X., Zhu, Q., Ji, S., Zhou, J., He, C., Ge, S., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27115089
“Despite its high prevalence, the pathogenesis of the disease remains elusive, and first-line treatments consisting of hormonal therapy and surgery are limited by high recurrence rates and significant adverse effects [5,6].”
Dubovecak, M., Turudić, T. P., Luetić, A. T., Hafner, D., Klenkar, M., Cvrtila, S., & Medić, N. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00346-w
Wu, E., Nassar, D., Ginn, D. N., & Romeroso, B. D. (2026) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002832
Marzec, U., Giza, A., Rajca, E., Cyrkler, A., Cieślak, N., Paulina, G. I. Z. A., Chodkowska, A., Czyżak, K., Dąbek, K., & Wymoczył, K. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5080
“Endometriosis is an estrogen-dependent gynecological disorder characterized by endometrial-like tissue formation outside the uterine cavity that is often localized to the ovaries, pelvic peritoneum, and in more severe cases the bowel or bladder (As-Sanie et al., 2013; Bulun et al., 2019).”
Dai, F., Tao, G., Zhang, J., Deng, Z., Yang, D., Chen, G., Sha, Y., & 尹太郎 (2026) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2026.10056
Physiopathologie de l’endométriose : plus de pistes que d’arrivées
Dabi, Y., Zerbib, E., Favier, A., Varinot, J., Dahan, M., Ferrier, C., Touboul, C., & Ilic, J. (2026) · EMC - Gynécologie · doi:10.1016/s0246-1064(26)48145-1
Ren, Y., Jin, Y., Li, X., Xu, R., Zhao, J., Su, L., & Wang, S. (2026) · Medicine · doi:10.1097/md.0000000000049486
Epidemiology of endometriosis and adenomyosis
Upson, K., Missmer, S. A., Tellum, T., Harris, H. R., & As‐Sanie, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00031-7
Маркін, Л. Б., Isayeva, K., Беседін, О. В., & Kunynets, H. (2026) · Lviv clinical bulletin · doi:10.25040/lkv2026.02.051
Metadata
- Authors
- Bulun, S. E., Yilmaz, B. D., Sison, C., Miyazaki, K., Bernardi, L., Liu, S., Kohlmeier, A., Yin, P., Milad, M., & Wei, J.
- Affiliations
- Northwestern University (US)
- Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
- Corresponding author
- Bulun, Serdar E
- ORCID
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-04-17
- Volume
- 40
- Issue
- 4
- Pages
- 1048-1079
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC6693056
- OpenAlex
- W4211072069
- Semantic Scholar
- 65040787dce0d5e2c5ea1422c1499c9646f18963
- Cited by
- 844
- References
- 214
- Citations by year
- 2026: 105 · 2025: 163 · 2024: 158 · 2023: 134 · 2022: 121 · 2021: 91 · 2020: 64 · 2019: 8
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Child Health and Human Development (HD38691)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- pelvic endometriosis, chronic pelvic pain, infertility, endometrial mesenchymal stem cells, epigenetic abnormalities, GATA6, steroidogenic factor 1, estrogen receptor beta, progesterone resistance, KRAS mutation, ovarian cancer, ovulation inhibition, cyclooxygenase inhibitors, in vitro fertilization, targeted therapy
- MeSH terms
- Animals, Endometriosis, Endometrium, Female, Humans, Receptors, Progesterone, Uterine Diseases, Stromal Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.